Cabot Corp.
CBT
NYSE·Basic Materials·Chemicals - Specialty·Mkt cap $4.2B
$81.48
▲ +0.36%
P/E
22.63
Mkt Cap
$4.2B
52-Wk Range
$58.33–$94.53
52-Week Range
$58.33 - $94.53
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 0.5% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- 140+ year heritage and deep expertise in carbon chemistry and materials science
- Diversified product portfolio serving multiple high-demand industries and end-markets
- Global distribution network with established relationships across Americas, Europe, EMEA, and Asia Pacific
- Proprietary manufacturing processes and technical capabilities in specialty materials
- Strong customer base including major automotive, tire, and industrial manufacturers
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising demand for high-performance materials in electric vehicle batteries and energy storage
Value
Undervalued - trading well below Specialty Chemicals peers
Momentum
Stable
+0.7% over 3m
Quality
Stable
Solid business
Dividend
Solid
2.26% yield
Smart-money signal
Who's buying CBT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 3, 2026
Reported EPS of $1.67 vs $1.65 consensus (+1.2% surprise). Revenue of $982.0M vs $943.2M expected (+4.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+1.2%
Revenue trend · last 8Q
—
-0%
-8%
-9%
-10%
-11%
-3%
+6%
Q4 24
Q1 24
Q2 25
Q3 25
Q4 25
Q1 25
Q2 26
Q3 26
$1.0B
$955.0M
$936.0M
$923.0M
$899.0M
$849.0M
$904.0M
$982.0M
Margins · last 8Q
Gross
18.7%
Operating
10.0%
Profit
0.6%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
67%
Sell
33%
Median Price Target
—
Latest: JP Morgan · May 13, 2026
vs Industry
How CBT stacks vs Chemicals - Specialty
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related